NasdaqCM - Nasdaq Real Time Price USD

The Oncology Institute, Inc. (TOI)

0.3017

+0.0028

+(0.94%)

At close: January 10 at 4:00:00 PM EST

Florida Blue enhances cancer care for thousands of members

New program aims to improve patient outcomes, experience, and quality of life by streamlining access to affordable and high-quality oncology careJACKSONVILLE, Fla., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Florida Blue, the state's leading health insurer, has launched a new comprehensive oncology care model designed to provide faster access to high-quality cancer care for its myBlue members. This patient-centric program, jointly developed by Florida Blue, Sanitas Medical Centers, and The Oncology Insti

GlobeNewswire 25 days ago

TOI
+0.94%
TOIIW
Oncology Institute Third Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.19 loss in 3Q 2023)

Oncology Institute ( NASDAQ:TOI ) Third Quarter 2024 Results Key Financial Results Revenue: US$99.9m (up 22% from 3Q...

Simply Wall St. last month

TOI
+0.94%
TOIIW
The Oncology Institute Reports Third Quarter 2024 Financial Results

CERRITOS, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three and nine months ended September 30, 2024. Recent Operational Highlights Include 79.9% increase in Dispensary segment revenue compared to prior year quarterWelcomed Rob Carter, as our new Chief Financial Officer3 new capitation contracts signed across 2

GlobeNewswire last month

TOI
+0.94%
TOIIW
The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California

TOI will be one of the few community-based practices on the West Coast to offer radiopharmaceuticals in the outpatient setting.CERRITOS, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Today, the Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) announced that they have received certification to begin administering Pluvicto therapy in their outpatient California radiation oncology practices. Pluvicto, a radiopharmaceutical used to treat certain types of metastatic prostate cancer, has previous

GlobeNewswire 2 months ago

TOI
+0.94%
TOIIW
The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call

CERRITOS, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its third quarter 2024 financial results after the market close on Wednesday, November 13, 2024, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international calle

GlobeNewswire 2 months ago

TOI
+0.94%
TOIIW
The Oncology Institute Joins Lantern’s Cancer Care Network of Excellence

CERRITOS, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the nation, has joined Lantern’s leading specialty care platform. Now, Lantern members will have access to cancer care at any of The Oncology Institute’s state-of-the-art community clinics across 5 states. “At TOI, we believe that every cancer patient deserves access to the most advanced care in their community,” said Dr. Dan Virnich, Chief Executive O

GlobeNewswire 2 months ago

TOI
+0.94%
TOIIW
The American Journal of Managed Care® and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care

CERRITOS, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Today, the Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) shared its partnership with the American Journal of Managed Care® (AJMC) to co-host a symposium focused on value-based cancer care. The event will take place on October 24, 2024, in Miami, Florida, as part of AJMC’s Institute for Value-Based Medicine (IVBM). The IVBM serves as a premier forum where leading expert faculty share their insights and experiences in implementing val

GlobeNewswire 2 months ago

TOI
+0.94%
TOIIW
The Oncology Institute of Hope & Innovation Launches Oregon Market

Anchor value-based payor partnership leads to opening of locations in Portland and SalemCERRITOS, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the nation, is proud to announce its expansion into Oregon with the opening of two new specialty cancer clinics. The clinic locations in Portland and Salem will mark TOI’s first capitated partnership in the market, with plans to expand to other markets in the state

GlobeNewswire 3 months ago

TOI
+0.94%
TOIIW
The Oncology Institute Announces CFO Transition

Rob Carter promoted to Chief Financial OfficerCERRITOS, Calif., Sept. 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), today announced that Chief Financial Officer, Mihir Shah, will transition out of the organization effective October 14, 2024, to pursue other opportunities. Rob Carter, Senior Vice President of Finance at TOI, will be promoted to Chief Financial Officer. Mr. Carter brings over a decade of finance leadership experience across sever

GlobeNewswire 3 months ago

TOI
+0.94%
TOIIW
The Oncology Institute Reports Second Quarter 2024 Financial Results and Updates Full Year 2024 Guidance

CERRITOS, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three and six months ended June 30, 2024 and updated its full year 2024 guidance. Recent Operational Highlights Include 76% increase in Dispensary segment revenue compared to prior year quarter3 new capitation contracts signed across 2 states including both m

GlobeNewswire 4 months ago

TOI
+0.94%
TOIIW
The Oncology Institute Announces Second Quarter 2024 Earnings Release Date and Conference Call

CERRITOS, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its second quarter 2024 financial results after the market close on Tuesday, August 13, 2024, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers,

GlobeNewswire 5 months ago

TOI
+0.94%
TOIIW
One Oncology Institute Insider Raised Stake By 720% In Previous Year

Insiders were net buyers of The Oncology Institute, Inc.'s ( NASDAQ:TOI ) stock during the past year. That is, insiders...

Simply Wall St. 6 months ago

TOI
+0.94%
TOIIW
The Oncology Institute to Participate at Upcoming Investor Conferences

CERRITOS, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI’s Chief Executive Officer, will participate at the following investor conferences: Jefferies Global Healthcare ConferenceDate: June 6th, 2024Fireside Chat: 9:00am Eastern TimeTOI Participant: Daniel Virnich, M.D., MBA, Chief Executive OfficerLocation: New York City, NY Truist Securities Health

GlobeNewswire 7 months ago

TOI
+0.94%
TOIIW
The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference

CERRITOS, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Today, the Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) have announced their executives’ participation in multiple panel presentations at the upcoming APG 2024 Spring Conference in San Diego. Chief Medical Officer, Dr. Yale Podnos, will be discussing artificial intelligence and its uses in an oncology practice in the breakout session panel “AI on the Front Lines: Improving Outcomes and Reducing Costs for Complex Patients”. Dr. Danie

GlobeNewswire 7 months ago

TOI
+0.94%
TOIIW
The Oncology Institute Inc (TOI) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...

TOI reports a robust revenue increase and strategic expansions, counterbalanced by margin pressures and operational losses in the first quarter of 2024.

GuruFocus.com 7 months ago

TOI
+0.94%
TOIIW
The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance

CERRITOS, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended March 31, 2024. Recent Operational Highlights Include: Successfully completed integration of first capitated risk contract direct to a health plan, and launched MSO model to enhance employed clinic locations, in the Florida market, effective

GlobeNewswire 7 months ago

TOI
+0.94%
TOIIW
The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit

CERRITOS, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI’s Chief Executive Officer, will participate in the “Defining the Next Chapter in Value-Based Care” panel at the Leerink Healthcare Transformation Summit in Montecito at 8:30am ET on May 16, 2024. About The Oncology Institute, Inc. Founded in 2007, The Oncology Institute, Inc. and its affiliate

GlobeNewswire 8 months ago

TOI
+0.94%
TOIIW
The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call

CERRITOS, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its first quarter 2024 financial results after the market close on Tuesday, May 14, 2024, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-

GlobeNewswire 8 months ago

TOI
+0.94%
TOIIW
Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute

Executive Brings Wealth of Experience in Advancing Value-Based Specialty Care Models CERRITOS, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is pleased to announce the appointment of Jordan McInerney as the new Chief Development Officer (CDO), effective April 1, 2024. In this role, Mr. McInerney will spearhead growth initiatives for The Oncology Institute across diverse markets, including cultivating new partnerships with payors, driving

GlobeNewswire 9 months ago

TOI
+0.94%
TOIIW
The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California

CERRITOS, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) and Healthly, a rapidly growing healthcare company with over 180 primary care physicians, support services, and a focus on preventive medicine, have announced a strategic collaboration aimed at extending high-quality cancer care services to patients throughout Southern California. Commencing July 1, 2024, TOI will offer its cancer care services to patients affiliated with Healthly’s

GlobeNewswire 9 months ago

TOI
+0.94%
TOIIW

Performance Overview

Return	TOI	S&P 500
YTD	-5.72%	-1.35%
1-Year	-84.99%	+22.51%
3-Year	-96.62%	+24.59%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

The Oncology Institute, Inc. (TOI)

Florida Blue enhances cancer care for thousands of members

Oncology Institute Third Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.19 loss in 3Q 2023)

The Oncology Institute Reports Third Quarter 2024 Financial Results

The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California

The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call

The Oncology Institute Joins Lantern’s Cancer Care Network of Excellence

The American Journal of Managed Care® and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care

The Oncology Institute of Hope & Innovation Launches Oregon Market

The Oncology Institute Announces CFO Transition

The Oncology Institute Reports Second Quarter 2024 Financial Results and Updates Full Year 2024 Guidance

The Oncology Institute Announces Second Quarter 2024 Earnings Release Date and Conference Call

One Oncology Institute Insider Raised Stake By 720% In Previous Year

The Oncology Institute to Participate at Upcoming Investor Conferences

The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference

The Oncology Institute Inc (TOI) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...

The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance

The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit

The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call

Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute

The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California

Performance Overview